1-3 of 3
Joanne Otani
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Phase I Study of Donor Regulatory T Cells As Treatment for Steroid Dependent/Refractory Chronic Graft Versus Host Disease

Laura Johnston, MD, Randall Armstrong, Jeanette Baker, PhD, Bita Sahaf, Joanne Otani, Keri Tate, PhD, Cynthia Tudisco, Kevin Sheehan, PhD, Everett Meyer, MD PhD, David Miklos, MD PhD, Robert S. Negrin, MD
Journal: Blood
Blood (2016) 128 (22): 385.
https://doi.org/10.1182/blood.V128.22.385.385
Published: 2016
Journal Articles

Ibrutinib Treatment of Relapsed CLL Following Allogeneic Transplantation: Sustained Disease Response and Promising Donor Immune Modulation

Christine E. Ryan, Aaron C. Logan, Andrew Rezvani, Manali Kamdar, Hideki Nakasone, Bita Sahaf, Joanne Otani, Katherine A Kong, Mark Klinger, Malek Faham, Steven Coutre, MD, David B. Miklos
Journal: Blood
Blood (2014) 124 (21): 1186.
https://doi.org/10.1182/blood.V124.21.1186.1186
Published: 2014
Journal Articles

A Dose Escalation Trial of Imatinib for Steroid Dependent Chronic Graft-Versus-Host Disease with Anti-PDGFRA Antibody Analysis.

George L. Chen, MD, Sally Arai, MD, Mary E.D. Flowers, MD, Joanne Otani, RN, MSN, Ethan C. Cheng, Alex McMillan, PhD, Wen-Kai Weng, MD, PhD, Judith Shizuru, PhD, MD, Laura Johnston, MD, David Miklos, MD, PhD
Journal: Blood
Blood (2009) 114 (22): 3304.
https://doi.org/10.1182/blood.V114.22.3304.3304
Published: 2009